# metoclopramide
- D2 antagonist @CTZ == antiemesis. muscarinic agonist/ d2 antagonism == gastroprokinesis/ increased sphincter tones/ ++peristalsis of the D/J
- *++nausea/vomiting esp in chemotherapy, peri-operative anti-emetic, hyperemesis gravidarum. *migraine, in combination with paracetamol/ aspirin. *gastroparesis/ GERD. *%%++lactation for breastfeeding
- common {akathisia, dizziness, headache, drowsiness}, uncommon {depression, EPSE esp tardive, hyper/hypotension, diarrhoea, constipation}, rare {neuroleptic malignant syndrome, agranulocytosis, arrhythmia, hyperaldosteronism}
- PBS pramin, PBS emexlon, PBS maxolon.
- considerations:
* CI @phaeo/ parkinsons
* CI @<1 yr old, use low doses @children @++EPSE
- dose:
* IM/ IV/ PO. IV given over 3 mins
* maximum length of treatment 5 days.
* N/V: up to 0.5 mg/kg or 30 mg, given TDS
* Chemo-N/V: up to 30mg, varies @chemo regime
* Gastroparesis: 5-10 mg 3 times daily
* half dose @CrCL < 10 ml/min
* increased dose @post-operative

# ondansetron
- mx
    + central and peripheral 5HT3 antagonist. central CTZ == -=N/V
- indications
    + N/V @postoperative/ radiotherapy/ chemotherapy
- SE
    + common {headache, constipation, ALT/AST transient increase}
    + rare {transient visual dx eg blurred vision, seizures, EPSE}
- considerations
    + reduce dose @hepatic impairment
    + @old reduce IV dose
    + @pregnant: after 1st trimester.
- brand:
    + PBS Zofran, PBS Zilfojim, PBS Zydis
- dosing:
    + post-op NV
        * prevent: IV/IM 4mg at induction or oral 16 mg 1 hr before induction
        * treat: IV/IM 4mg. PRN
    + cancer chemotherapy NV
        * prevent: IV 8-12 mg. max 8 @>75 years before, or 16-24 mg oral 1-2 hrs before chemo.
        * maintenance: PO 8mg ev 12 hrs for up to 5/7 after cycle.
    + radiotherapy NV
        * PO 8mg ev 12 hrs up to 5/7
    + @hepatic failure
        * do not exceed 8mg daily